collaborators

10 papers

cs.LG2026

La-Proteina: Atomistic Protein Generation via Partially Latent Flow Matching

Tomas Geffner, Kieran Didi, Zhonglin Cao +6

Recently, many generative models for de novo protein structure design have emerged. Yet, only few tackle the difficult task of directly generating fully atomistic structures jointl…

cs.LG2026

Scaling Atomistic Protein Binder Design with Generative Pretraining and Test-Time Compute

Kieran Didi, Zuobai Zhang, Guoqing Zhou +11

Protein interaction modeling is central to protein design, which has been transformed by machine learning with applications in drug discovery and beyond. In this landscape, structu…

cs.LG2026

General Binding Affinity Guidance for Diffusion Models in Structure-Based Drug Design

Yue Jian, Curtis Wu, Danny Reidenbach +1

Structure-based drug design (SBDD) aims to generate ligands that bind strongly and specifically to target protein pockets. Recent diffusion models have advanced SBDD by capturing t…

cs.LG2026

Exploring Synthesizable Chemical Space with Iterative Pathway Refinements

Seul Lee, Karsten Kreis, Srimukh Prasad Veccham +5

A well-known pitfall of molecular generative models is that they are not guaranteed to generate synthesizable molecules. Existing solutions for this problem often struggle to effec…

q-bio.BM2025

Consistent Synthetic Sequences Unlock Structural Diversity in Fully Atomistic De Novo Protein Design

Danny Reidenbach, Zhonglin Cao, Zuobai Zhang +8

High-quality training datasets are crucial for the development of effective protein design models, but existing synthetic datasets often include unfavorable sequence-structure pair…

cs.LG2025

BioNeMo Framework: a modular, high-performance library for AI model development in drug discovery

Peter St. John, Dejun Lin, Polina Binder +89

Artificial Intelligence models encoding biology and chemistry are opening new routes to high-throughput and high-quality in-silico drug development. However, their training increas…